Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine

Abstract

The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced as a mandatory vaccine in Bulgaria in April 2010. We report on the serotype distribution and the antimicrobial resistance of 222 invasive Streptococcus pneumoniae isolates collected from all age groups before the introduction of PCV10. PCV7, PCV10, and PCV13 covered 43·7, 59·9, and 78·8% of all invasive pneumococcal strains, and 64·2, 79·1, and 89·6% of isolates involving children less than 5 years of age. Penicillin resistance was found in 30·1% of the isolates responsible for meningitis and in 5·0% of isolates responsible for other invasive infections. Overall, erythromycin resistance was found in 19·4% of all invasive strains. The erm(B) was the most prevalent pneumococcal macrolide resistance genotype (63·2%) and dual mechanisms of both genes the erm(B) and mef(E) were detected in 15·8% of 19 erythromycin resistant isolates during the period 2006–2010. The prevalence and spread of serotypes 19F, 6B, and 19A during the last period may have contributed to the high predominance of erm(B) genotype in comparison of mef genotype, which was predominant in our country among erythromycin-resistant isolates before 2005. Continuing surveillance is required after the recent introduction of PCV10 in order to observe future developments of any serotype changes in the Bulgarian population, as well as surveillance of antimicrobial susceptibility of invasive S. pneumoniae isolates.

Keywords:

• Pneumococcal conjugate vaccine
• Serotypes
• Antibiotic resistance
• S. pneumoniae

The study was partially supported by Medical University of Sofia-Grant No.D9/2008. Members of the Group for Microbiological surveillance of pneumococci include I. Haydoushka and M. Murdjeva (University Hospital of Plovdiv), M. Sredkova (University Hospital of Pleven), K. Bojkova (University Hospital of Varna), B. Markova and Y. Proevska (Alexandrovska University Hospital, Sofia), Ts. Velinov and A. Kuzmanov (NCIPD, Sofia), N. Modeva and Semkova (National Hospital for Cardiology, Sofia), P. Panova (HID, Sofia). We thank all microbiological laboratories in Bulgaria for their cooperation and for providing the isolates.